Venus Legacy and Venus Versa Launch in Cochin

Kochi, April 13, 2016: Venus Concept, a revolutionary leader in the field of medical aesthetics industry launches their powerful and advanced aesthetic treatment devices – Venus Legacy and Venus Versa in Cochin this April.

Commenting on the launch, Dr. Joy Shah, Partner and Strategic Consultant, Venus Aesthetics LLP, “Venus India has established a strong presence in the West, with our footprints in North, East and South zone as well. With Venus Legacy and Venus Versa launch in Cochin, we are moving towards our vision of expanding base across the country, in tier-2 cities, ensuring that the wide-ranging Venus treatments that are both effective and affordable, are available to everyone.”

The launch of the devices is celebrated via a Signature Venus Beauty Event hosted by Venus Concept India and Dr. George Varghese Koluthara, MD of Doctors Aesthetics Centre in Cochin. The event features a Treatment Bar where the guests experience ‘express treatment’ on their problem areas such as jaw line, skin texture, pigmentation, fine lines etc through Venus Viva and Venus Legacy – Venus Concept’s two most popular treatment devices.

Dr. George Koluthara, MD of Doctors Aesthetics Centre and a pioneer in the field of laser skin treatment in Kerala said, “Doctors Aesthetic Centre is an advanced centre for skin laser and cosmetic procedures. We have the latest laser treatment machines to treat various hair and skin concerns. Since the past few months we have been using Venus Viva and Venus Legacy and we are pleased with the fantastic results on our patients. We are now introducing Venus Versa at the clinic to treat pigmented lesions, vascular lesions and hair removal.”

Doctors Aesthetics Centre popularly known as “DAC Skin Laser Treatment” centre is an advanced centre for skin laser and cosmetic procedures located at Palarivattom, Cochin, Kerala. DAC is specialized in various cosmetic procedures like Botox treatment, Dermal fillers, Vampire facelift, Dermal thread lift, Chemical peeling, Platelet Rich Plasma Treatment, Radiance Facial, Collagen Induction Therapy, Electroporation etc. It is equipped with most advanced laser machines for treatments like Permanent Hair Reduction, Stretch Marks, Facial Wrinkles, Acne Scars, Black Mole, Tattoo Removal, Melasma, Warts, Corns, Skin Tag, Aging Black Spots, Neurofibromatosis, Xanthelasma Molluscum Contagiosum, Sebaceous Cyst, Capillary Haemangioma, Trichilemmoma, Milia, Seborrheic Keratosis, Keloid, Tuberous Sclerosis and more.

Venus Concept is a revolutionary leader in the medical aesthetics industry with 15 years of experience in the field of dermatology. The company through its own Research & Development and by investing extensive resources in developing devices has created cutting edge technologies that are safe, painless and affordable. Venus Concept is present in over 50+ countries with over 3,000,000+ treatments performed in a year globally.

Venus Concept offers an extensive range of aesthetics treatments through their diverse portfolio of devices with Venus Viva and Venus Legacy being two such devices that will be used for the express treatment at the event. Venus Viva is the next generation in Skin Resurfacing and Facial Remodelling, combining NanoFractional Radio Frequency and SmartScan technology to effectively treat textural irregularities, scarring, wrinkles and stretch marks.

On the other hand, Venus Legacy for face, neck and body is a non-invasive treatment that uses Multi-Polar Radio Frequency, VariPulse Technology and Pulsed Electro Magnetic Fields to soften deep wrinkles, contour fat pockets, reduce volume, tighten skin and dramatically reduce cellulite to give a firm and enhanced body shape.

Venus treatments are popular among Doctors and Patients alike because of advanced and effective technology, pain-free and comfortable treatment experience, no downtime post treatment, safe for all skin types and optimal outcomes.

All Venus treatment devices used in India are USFDA, Health Canada and European CE Approved.

Corporate Comm India (CCI Newswire)